tiprankstipranks
Trending News
More News >
Exosens (FR:EXENS)
:EXENS
France Market
Advertisement

Exosens (EXENS) Stock Forecast & Price Target

Compare
8 Followers
See the Price Targets and Ratings of:

EXENS Analyst Ratings

Moderate Sell
1Ratings
Moderate Sell
0 Buy
0 Hold
1 Sell
Based on 1 analysts giving stock ratings to
Exosens
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EXENS Stock 12 Month Forecast

Average Price Target

€33.00
▼(-19.32%Downside)
Based on 1 Wall Street analysts offering 12 month price targets for Exosens in the last 3 months. The average price target is €33.00 with a high forecast of €33.00 and a low forecast of €33.00. The average price target represents a -19.32% change from the last price of €40.90.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"€16","45":"€45","23.25":"€23.3","30.5":"€30.5","37.75":"€37.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€33.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€33.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€33.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,23.25,30.5,37.75,45],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.3,38.815384615384616,38.33076923076923,37.84615384615385,37.36153846153846,36.87692307692308,36.39230769230769,35.90769230769231,35.42307692307692,34.93846153846154,34.45384615384615,33.96923076923077,33.48461538461538,{"y":33,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.3,38.815384615384616,38.33076923076923,37.84615384615385,37.36153846153846,36.87692307692308,36.39230769230769,35.90769230769231,35.42307692307692,34.93846153846154,34.45384615384615,33.96923076923077,33.48461538461538,{"y":33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.3,38.815384615384616,38.33076923076923,37.84615384615385,37.36153846153846,36.87692307692308,36.39230769230769,35.90769230769231,35.42307692307692,34.93846153846154,34.45384615384615,33.96923076923077,33.48461538461538,{"y":33,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.75,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.75,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.75,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.95,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.95,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.55,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.65,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.4,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.38,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.92,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.33,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.15,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.3,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€33.00Average Price Target€33.00Lowest Price Target€33.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on FR:EXENS
TipRanks AITipRanks
Not Ranked
TipRanks
€44
Hold
7.58%
Upside
Reiterated
07/31/25
The overall stock score for Exosens is primarily driven by its strong financial performance, which is a major positive. However, the high P/E ratio raises valuation concerns, and technical analysis suggests mixed signals, with some potential for short-term price volatility.
Kepler Capital  Analyst forecast on FR:EXENS
Aymeric PoulainKepler Capital
Kepler Capital
€33
Sell
-19.32%
Downside
Reiterated
07/30/25
Stifel Nicolaus Analyst forecast on FR:EXENS
Alexander WahlStifel Nicolaus
Stifel Nicolaus
€38
Buy
-7.09%
Downside
Reiterated
04/28/25
Stifel Reiterates Buy Rating on Exosens SAS (EXENS:FP)Stifel analyst Alexander Wahl reiterated a Buy rating and EUR38.00 price target on Exosens SAS (EXENS:FP).
Citi
€29€37
Hold
-9.54%
Downside
Initiated
03/26/25
Exosens (EXENS) Gets a Hold from Citi
Bernstein
€45.5
Buy
11.25%
Upside
Reiterated
03/19/25
Exosens' Strategic Expansion and Strong Financial Outlook Earns Buy Rating and Top 10 European SMID Selection
J.P. Morgan Analyst forecast on FR:EXENS
David PerryJ.P. Morgan
J.P. Morgan
€28.5€33.5
Buy
-18.09%
Downside
Reiterated
03/03/25
Exosens SAS (EXENS:FP) PT Raised to EUR33.50 at JPMorganJPMorgan analyst David Perry raised the price target on Exosens SAS (EXENS:FP) to EUR33.50 (from EUR28.50) while maintaining a Overweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on FR:EXENS
TipRanks AITipRanks
Not Ranked
TipRanks
€44
Hold
7.58%
Upside
Reiterated
07/31/25
The overall stock score for Exosens is primarily driven by its strong financial performance, which is a major positive. However, the high P/E ratio raises valuation concerns, and technical analysis suggests mixed signals, with some potential for short-term price volatility.
Kepler Capital  Analyst forecast on FR:EXENS
Aymeric PoulainKepler Capital
Kepler Capital
€33
Sell
-19.32%
Downside
Reiterated
07/30/25
Stifel Nicolaus Analyst forecast on FR:EXENS
Alexander WahlStifel Nicolaus
Stifel Nicolaus
€38
Buy
-7.09%
Downside
Reiterated
04/28/25
Stifel Reiterates Buy Rating on Exosens SAS (EXENS:FP)Stifel analyst Alexander Wahl reiterated a Buy rating and EUR38.00 price target on Exosens SAS (EXENS:FP).
Citi
€29€37
Hold
-9.54%
Downside
Initiated
03/26/25
Exosens (EXENS) Gets a Hold from Citi
Bernstein
€45.5
Buy
11.25%
Upside
Reiterated
03/19/25
Exosens' Strategic Expansion and Strong Financial Outlook Earns Buy Rating and Top 10 European SMID Selection
J.P. Morgan Analyst forecast on FR:EXENS
David PerryJ.P. Morgan
J.P. Morgan
€28.5€33.5
Buy
-18.09%
Downside
Reiterated
03/03/25
Exosens SAS (EXENS:FP) PT Raised to EUR33.50 at JPMorganJPMorgan analyst David Perry raised the price target on Exosens SAS (EXENS:FP) to EUR33.50 (from EUR28.50) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Exosens

1 Month
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
+1.41%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.41% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
+18.44%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +18.44% per trade.
1 Year
Aymeric PoulainKepler Capital
Success Rate
7/8 ratings generated profit
88%
Average Return
+45.69%
reiterated a sell rating 5 days ago
Copying Aymeric Poulain's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +45.69% per trade.
2 Years
xxx
Success Rate
7/8 ratings generated profit
88%
Average Return
+45.69%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +45.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EXENS Analyst Recommendation Trends

Rating
Jan 25
Mar 25
Apr 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
7
9
8
5
1
Hold
0
2
3
4
7
Sell
0
0
0
1
2
Strong Sell
0
0
0
0
0
total
7
11
11
10
10
In the current month, EXENS has received 1 Buy Ratings, 7 Hold Ratings, and 2 Sell Ratings. EXENS average Analyst price target in the past 3 months is 33.00.
Each month's total comprises the sum of three months' worth of ratings.

EXENS Financial Forecast

EXENS Earnings Forecast

The previous quarter’s earnings for EXENS were €0.55.
The previous quarter’s earnings for EXENS were €0.55.

EXENS Sales Forecast

The previous quarter’s earnings for EXENS were €224.51M.
The previous quarter’s earnings for EXENS were €224.51M.

EXENS Stock Forecast FAQ

What is FR:EXENS’s average 12-month price target, according to analysts?
Based on analyst ratings, Exosens’s 12-month average price target is 33.00.
    What is FR:EXENS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for FR:EXENS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Exosens a Buy, Sell or Hold?
        Exosens has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 1 sell ratings.
          What is Exosens’s share price target?
          The average share price target for Exosens is 33.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €33.00 ,and the lowest forecast is €33.00. The average share price target represents -19.32% Decrease from the current price of €40.9.
            What do analysts say about Exosens?
            Exosens’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 1 Wall Streets Analysts.
              How can I buy shares of Exosens?
              To buy shares of FR:EXENS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis